NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 56 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,000 | +150.0% | 14,881 | +196.5% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 5,019 | -12.6% | 0.00% | – |
| Q3 2017 | $2,000 | -92.0% | 5,744 | -88.3% | 0.00% | -100.0% |
| Q2 2017 | $25,000 | +19.0% | 49,072 | +25.6% | 0.00% | +50.0% |
| Q2 2016 | $21,000 | -8.7% | 39,069 | +123.6% | 0.00% | -50.0% |
| Q4 2015 | $23,000 | +4.5% | 17,472 | +87.6% | 0.00% | +100.0% |
| Q3 2015 | $22,000 | +340.0% | 9,315 | +187.7% | 0.00% | – |
| Q2 2015 | $5,000 | +25.0% | 3,238 | +30.6% | 0.00% | – |
| Q1 2015 | $4,000 | -60.0% | 2,479 | -54.7% | 0.00% | -100.0% |
| Q4 2014 | $10,000 | -89.4% | 5,472 | -92.3% | 0.00% | -90.9% |
| Q3 2014 | $94,000 | +248.1% | 71,463 | +286.6% | 0.01% | +266.7% |
| Q2 2014 | $27,000 | +440.0% | 18,483 | +718.6% | 0.00% | +200.0% |
| Q4 2013 | $5,000 | – | 2,258 | +1781.7% | 0.00% | – |
| Q3 2013 | $0 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|